These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 17983387

  • 1. Oral reactions to sublingual immunotherapy: a bioptic study.
    Marcucci F, Sensi L, Incorvaia C, Di Cara G, Moingeon P, Frati F.
    Allergy; 2007 Dec; 62(12):1475-7. PubMed ID: 17983387
    [No Abstract] [Full Text] [Related]

  • 2. Clinical trial shows sublingual immunotherapy to be effective for treatment of children with grass pollen allergy.
    Wilkinson J.
    Immunotherapy; 2012 Nov; 4(11):1091-2. PubMed ID: 23194357
    [No Abstract] [Full Text] [Related]

  • 3. Sublingual immunotherapy.
    Frew AJ.
    N Engl J Med; 2008 May 22; 358(21):2259-64. PubMed ID: 18499568
    [No Abstract] [Full Text] [Related]

  • 4. Simultaneous SCIT with 2 separate allergen extracts demonstrates comparable safety compared to SCIT with a single allergen extract.
    Röder A, Darrelmann N, Klingenberg W, Krüll M, Suttorp N, Noga O.
    J Investig Allergol Clin Immunol; 2009 May 22; 19(6):512-3. PubMed ID: 20128433
    [No Abstract] [Full Text] [Related]

  • 5. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
    Panzner P, Petrás M, Sýkora T, Lesná I.
    Respir Med; 2008 Sep 22; 102(9):1296-304. PubMed ID: 18585908
    [Abstract] [Full Text] [Related]

  • 6. Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile.
    Calderón MA, Simons FE, Malling HJ, Lockey RF, Moingeon P, Demoly P.
    Allergy; 2012 Mar 22; 67(3):302-11. PubMed ID: 22150126
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and its persistence, in children and adults.
    Di Rienzo V.
    Int J Immunopathol Pharmacol; 2005 Mar 22; 18(4 Suppl):35-7. PubMed ID: 17761106
    [No Abstract] [Full Text] [Related]

  • 8. Susceptibility of a grass-pollen oral immunotherapy extract to the saliva and gastric fluid digestive process.
    Igea JM, Cuevas M, Lázaro M, Quirce S, Cuesta J.
    Allergol Immunopathol (Madr); 1994 Mar 22; 22(2):55-9. PubMed ID: 8059676
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and tolerability of high dose sublingual immunotherapy in patients with rhinoconjunctivitis.
    Worm M.
    Eur Ann Allergy Clin Immunol; 2006 Dec 22; 38(10):355-60. PubMed ID: 17274520
    [Abstract] [Full Text] [Related]

  • 10. Anaphylaxis caused by allergen sublingual immunotherapy?
    André C, Fadel R.
    Allergy; 2007 Oct 22; 62(10):1220-1. PubMed ID: 17845597
    [No Abstract] [Full Text] [Related]

  • 11. Sublingual immunotherapy: focus on tablets.
    Passalacqua G, Canonica GW.
    Ann Allergy Asthma Immunol; 2015 Jul 22; 115(1):4-9. PubMed ID: 26123419
    [No Abstract] [Full Text] [Related]

  • 12. Distribution of Langerhans cells and mast cells within the human oral mucosa: new application sites of allergens in sublingual immunotherapy?
    Allam JP, Stojanovski G, Friedrichs N, Peng W, Bieber T, Wenzel J, Novak N.
    Allergy; 2008 Jun 22; 63(6):720-7. PubMed ID: 18445186
    [Abstract] [Full Text] [Related]

  • 13. Update on sublingual immunotherapy treatment regimes.
    Spangfort MD.
    Eur Ann Allergy Clin Immunol; 2006 Sep 22; 38(7):244. PubMed ID: 17124783
    [No Abstract] [Full Text] [Related]

  • 14. [The mechanisms of allergen-specific immunotherapy more clear].
    Rak S.
    Lakartidningen; 2006 Sep 22; 105(26-27):1935-7. PubMed ID: 18681375
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of high-doses sublingual immunotherapy in ultra-rush scheme in children allergic to grass pollen.
    Stelmach I, Kaczmarek-Woźniak J, Majak P, Olszowiec-Chlebna M, Jerzynska J.
    Clin Exp Allergy; 2009 Mar 22; 39(3):401-8. PubMed ID: 19134016
    [Abstract] [Full Text] [Related]

  • 16. LAIS - Posological schedules.
    Bruno M.
    Int J Immunopathol Pharmacol; 2005 Mar 22; 18(4 Suppl):33-4. PubMed ID: 17761105
    [No Abstract] [Full Text] [Related]

  • 17. Response to sublingual immunotherapy with grass pollen extract: monotherapy versus combination in a multiallergen extract.
    Amar SM, Harbeck RJ, Sills M, Silveira LJ, O'Brien H, Nelson HS.
    J Allergy Clin Immunol; 2009 Jul 22; 124(1):150-156.e1-5. PubMed ID: 19523672
    [Abstract] [Full Text] [Related]

  • 18. The biological potency of different extracts for sublingual immunotherapy assessed by skin prick tests.
    Rossi R, Monasterolo G, Passalacqua G.
    Eur Ann Allergy Clin Immunol; 2010 Jun 22; 42(3):112-4. PubMed ID: 20648773
    [Abstract] [Full Text] [Related]

  • 19. Survey on the safety of a no-updosing regimen of sublingual immunotherapy.
    Musarra A, Cilia M, Pecora S, Passalacqua G.
    Eur Ann Allergy Clin Immunol; 2006 Nov 22; 38(9):313-4. PubMed ID: 17191752
    [No Abstract] [Full Text] [Related]

  • 20. Grazax sublingual immunotherapy in pre-co-seasonal and continuous treatment regimens: is there a difference in clinical efficacy?
    Nakonechna A, Hills J, Moor J, Dore P, Abuzakouk M.
    Ann Allergy Asthma Immunol; 2015 Jan 22; 114(1):73-4. PubMed ID: 25457868
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.